# Septodont and Acteon to acquire Inibsa

Septodont and Acteon have signed an agreement to become shareholders of Inibsa, a global pharmaceutical group based in Barcelona, Spain. Septodont will acquire a controlling stake, with Acteon as a non-controlling shareholder. The deal is subject to regulatory approvals.

- Type: Acquisition
- Announced: 2024-09-03
- Where: Barcelona, Spain, Spain
- Status: announced
- Products: dental products, pharmaceutical products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Inibsa Group](https://endata.com/companies/21123.md) (target)
- [Septodont](https://endata.com/companies/23657.md) (acquirer)
- [Acteon](https://endata.com/companies/38654.md) (investor)

## Sources

- [septodontcorp.com](https://www.septodontcorp.com/news/septodont-and-acteon-announce-the-signing-of-an-agreement-by-which-both-septodont-and-acteon-will-become-the-shareholders-of-inibsa/), 2024-09-03: "This acquisition of control of Inibsa will expand Septodont’s development in dental products and help us further strengthen our geographical footprint."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.